Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
76.10
+5.65 (8.02%)
Aug 20, 2026, 4:09 PM HKT
Nanjing Leads Biolabs Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Hold Maintains $62.00 → $79.00 | Hold | Maintains | $62.00 → $79.00 | +3.81% | Jul 21, 2026 |
Unknown Analyst CLSA No rating | CLSA | Buy Maintains $108.00 | Buy | Maintains | $108.00 | +41.92% | Jul 13, 2026 |
Unknown Analyst GF Securities No rating | GF Securities | Buy Maintains $110.96 | Buy | Maintains | $110.96 | +45.81% | Apr 28, 2026 |
Unknown Analyst Orient Securities No rating | Orient Securities | Buy Maintains $81.01 → $103.06 | Buy | Maintains | $81.01 → $103.06 | +35.43% | Apr 21, 2026 |
Unknown Analyst Huafu Securities No rating | Huafu Securities | Buy Maintains $101.90 → $140.75 | Buy | Maintains | $101.90 → $140.75 | +84.95% | Apr 15, 2026 |
Andy Wang CMB International Securities No rating | CMB International Securities | Buy Maintains $100.50 | Buy | Maintains | $100.50 | +32.06% | Mar 31, 2026 |